Briacell Therapeutics (BCTX) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access BCTX Annual Balance Sheets →
The data below summarizes Briacell Therapeutics's balance sheet position from Apr 30 2025 to Apr 30 2026, enabling a period-by-period comparison of financial strength.
Quarterly Report, GAAP in USD millions
ITEM
(Apr 30 2026)
(Jan 31 2026) (Oct 31 2025) (Jul 31 2025) (Apr 30 2025)
Assets
Cash & cash equivalent6.88
Short-term Investments, Total15.92
Cash & Short-term Investments21.00
Other Current Assets2.59
Prepaid Expense, Current AS0.00
Total Current Assets25.39
Equipment/Property/Plant Net0.35
Intangible Assets0.17
Tax Assets, Noncurrent0.00
Prepaid Expense, Noncurrent, Total PR0.41
Other Assets, Noncurrent0.00
Accounts Receivable And Prepaid Expenses Current2.59
Equity Securities F V N I Noncurrent0.75
Total Assets27.07
Liabilities
Accounts Payable1.42
Other Liabilities, Current2.17
Total Current Liabilities3.59
Total Long-term Debt0.00
Derivative Liability, Noncurrent DE0.07
Accrued Income Taxes, Noncurrent0.00
Total Liabilities3.66
Stockholders' Equity
Warrant Reserve30.22
Sharebased Payment Reserve11.20
Common Stock Value117.12
Retained Earnings / Accumulated Deficit-134.34
Accumulated Other Comprehensive Income0.00
Other Equity-0.14
Common Stockholder's Equity24.06
Non-controlling interests & other-0.65
Total Stockholder's Equity23.41
Liabilities & Stockholder's Equity27.07
4 historic quarters locked

Sign in to unlock the full Briacell Therapeutics balance sheet history.

About Briacell Therapeutics Corp Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q (Period: 20260430)
  • Filed with the SEC: June 9, 2026
  • Source: form10-q.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001493152-26-027928

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.